Your browser doesn't support javascript.
loading
Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor.
Curti, Brendan D; Koguchi, Yoshinobu; Leidner, Rom S; Rolig, Annah S; Sturgill, Elizabeth R; Sun, Zhaoyu; Wu, Yaping; Rajamanickam, Venkatesh; Bernard, Brady; Hilgart-Martiszus, Ian; Fountain, Christopher B; Morris, George; Iwamoto, Noriko; Shimada, Takashi; Chang, ShuChing; Traber, Peter G; Zomer, Eliezer; Horton, J Rex; Shlevin, Harold; Redmond, William L.
Affiliation
  • Curti BD; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Koguchi Y; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Leidner RS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Rolig AS; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Sturgill ER; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Sun Z; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Wu Y; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Rajamanickam V; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Bernard B; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Hilgart-Martiszus I; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Fountain CB; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Morris G; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA.
  • Iwamoto N; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Shimada T; Shimadzu Bioscience Research Partnership, Shimadzu Scientific Instruments, Bothell, Washington, USA.
  • Chang S; Medical Data Research Center, Providence St Joseph Health, Portland, Oregon, USA.
  • Traber PG; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Zomer E; Galectin Therapeutics, Norcross, Georgia, USA.
  • Horton JR; Galectin Therapeutics, Norcross, Georgia, USA.
  • Shlevin H; Galectin Therapeutics, Norcross, Georgia, USA.
  • Redmond WL; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, Oregon, USA william.redmond@providence.org.
J Immunother Cancer ; 9(4)2021 04.
Article in En | MEDLINE | ID: mdl-33837055
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Blood Proteins / Antineoplastic Combined Chemotherapy Protocols / Pectins / Galectins / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Squamous Cell Carcinoma of Head and Neck / Immune Checkpoint Inhibitors / Head and Neck Neoplasms / Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Blood Proteins / Antineoplastic Combined Chemotherapy Protocols / Pectins / Galectins / Antibodies, Monoclonal, Humanized / Programmed Cell Death 1 Receptor / Squamous Cell Carcinoma of Head and Neck / Immune Checkpoint Inhibitors / Head and Neck Neoplasms / Multiple Myeloma Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Immunother Cancer Year: 2021 Document type: Article